Pharma Excipients

News on Pharma Excipients

Formulation of semi-solid dosage forms indented for transdermal delivery of ivermectin

The story of ivermectin originated in 1974, when scientist Satoshi Omura discovered Streptomyces avermitilis, which later led to the isolation of an active compound, avermectin and finally, ivermectin . Ivermectin, which consists of two homologs (namely dihydro-avermectin B1b and dihydro-avermectin B1a) , is a broad-spectrum anti-parasitic drug. It…

Oral biologics delivery still elusive

29. February 2016 Despite decades of effort, oral delivery of peptide, protein and antibody drugs remains a major pharmaceutical challenge, with only a handful of products on the market. That is particularly disappointing as…
Read More...